Budget Amount *help |
¥322,790,000 (Direct Cost: ¥248,300,000、Indirect Cost: ¥74,490,000)
Fiscal Year 2014: ¥60,060,000 (Direct Cost: ¥46,200,000、Indirect Cost: ¥13,860,000)
Fiscal Year 2013: ¥62,790,000 (Direct Cost: ¥48,300,000、Indirect Cost: ¥14,490,000)
Fiscal Year 2012: ¥65,650,000 (Direct Cost: ¥50,500,000、Indirect Cost: ¥15,150,000)
Fiscal Year 2011: ¥65,130,000 (Direct Cost: ¥50,100,000、Indirect Cost: ¥15,030,000)
Fiscal Year 2010: ¥69,160,000 (Direct Cost: ¥53,200,000、Indirect Cost: ¥15,960,000)
|
Outline of Final Research Achievements |
We have identified and characterized genes involved in the tumorigenicity of glioblastoma and colon cancer cells and obtained the following results: 1) PCDH10, PCDH17, PTPRD, SOX9, LGR5, ALK, Pleiotrophin and TET1 play important roles in the tumorigenicity of glioblastoma cells.2) Endothelial DLL4 induces Notch3-Asef pathway-mediated cell migration.3) TET1-mediated production of 5-hydroxymethylcytosine (5hmC) is required for the tumorigenicity of glioblastoma cells. 5hmC recruites the CHTOP-methylosome complex to selective sites on the chromosome, where it methylates H4R3 and activates transcription of cancer-related genes.
|